Toda E - Search Results

1

Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation.

Miyabe C, Miyabe Y, Miura NN, Takahashi K, Terashima Y, Toda E, Honda F, Morio T, Yamagata N, Ohno N, Shudo K, Suzuki J, Isobe M, Matsushima K, Tsuboi R, Miyasaka N, Nanki T. Miyabe C, et al. Among authors: toda e. Arthritis Rheum. 2013 Feb;65(2):503-12. doi: 10.1002/art.37784. Arthritis Rheum. 2013. PMID: 23203767 Free article.

2

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, Narumi S, Lu B, Gerard C, Ishikawa S, Matsushima K. Yoneyama H, et al. Among authors: toda e. J Exp Med. 2005 Aug 1;202(3):425-35. doi: 10.1084/jem.20041961. J Exp Med. 2005. PMID: 16061729 Free PMC article.

3

[FROUNT, a regulator of monocytes/macrophage chemotaxis].

Toda E, Terashima Y. Toda E, et al. Seikagaku. 2007 Oct;79(10):972-5. Seikagaku. 2007. PMID: 18027578 Review. Japanese. No abstract available.

4

FROUNT is a common regulator of CCR2 and CCR5 signaling to control directional migration.

Toda E, Terashima Y, Sato T, Hirose K, Kanegasaki S, Matsushima K. Toda E, et al. J Immunol. 2009 Nov 15;183(10):6387-94. doi: 10.4049/jimmunol.0803469. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841162

5

Expression and purification of human FROUNT, a common cytosolic regulator of CCR2 and CCR5.

Esaki K, Terashima Y, Toda E, Yoshinaga S, Araki N, Matsushima K, Terasawa H. Esaki K, et al. Among authors: toda e. Protein Expr Purif. 2011 May;77(1):86-91. doi: 10.1016/j.pep.2010.12.012. Epub 2010 Dec 28. Protein Expr Purif. 2011. PMID: 21193048

6

[Molecular targeting drugs for immune and inflammatory diseases].

Toda E, Terashima Y, Matsushima K. Toda E, et al. Nihon Rinsho. 2012 Nov;70 Suppl 8:365-71. Nihon Rinsho. 2012. PMID: 23513867 Japanese. No abstract available.

7

Identification of a binding element for the cytoplasmic regulator FROUNT in the membrane-proximal C-terminal region of chemokine receptors CCR2 and CCR5.

Toda E, Terashima Y, Esaki K, Yoshinaga S, Sugihara M, Kofuku Y, Shimada I, Suwa M, Kanegasaki S, Terasawa H, Matsushima K. Toda E, et al. Biochem J. 2014 Jan 15;457(2):313-22. doi: 10.1042/BJ20130827. Biochem J. 2014. PMID: 24128342

8

Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT.

Esaki K, Yoshinaga S, Tsuji T, Toda E, Terashima Y, Saitoh T, Kohda D, Kohno T, Osawa M, Ueda T, Shimada I, Matsushima K, Terasawa H. Esaki K, et al. Among authors: toda e. FEBS J. 2014 Dec;281(24):5552-66. doi: 10.1111/febs.13096. Epub 2014 Nov 4. FEBS J. 2014. PMID: 25283965 Free article.

9

Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice.

Ueha S, Yokochi S, Ishiwata Y, Ogiwara H, Chand K, Nakajima T, Hachiga K, Shichino S, Terashima Y, Toda E, Shand FH, Kakimi K, Ito S, Matsushima K. Ueha S, et al. Among authors: toda e. Cancer Immunol Res. 2015 Jun;3(6):631-40. doi: 10.1158/2326-6066.CIR-14-0190. Epub 2015 Feb 20. Cancer Immunol Res. 2015. PMID: 25711759

10

Identification and Preparation of a Novel Chemokine Receptor-Binding Domain in the Cytoplasmic Regulator FROUNT.

Sonoda A, Yoshinaga S, Yunoki K, Ezaki S, Yano K, Takeda M, Toda E, Terashima Y, Matsushima K, Terasawa H. Sonoda A, et al. Among authors: toda e. Mol Biotechnol. 2017 May;59(4-5):141-150. doi: 10.1007/s12033-017-0002-2. Mol Biotechnol. 2017. PMID: 28342149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters